Sequencing Reagents Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Sequencing Reagents Market, By Technology

7.1.  Sequencing Reagents Market, By Technology, 2020-2028

7.1.1.    Sanger Sequencing

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Next-Generation Sequencing

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Third Generation Sequencing

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Sequencing Reagents Market, By Reagent Type

8.1.  Sequencing Reagents Market, By Reagent Type, 2020-2028

8.1.1.    Library Kits

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Template Kits

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Control Kits

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Sequencing Kits

8.1.4.1.        Market Revenue and Forecast (2016-2028)  

Chapter 9.  Global Sequencing Reagents Market, By End User

9.1.  Sequencing Reagents Market, by End User, 2020-2028

9.1.1.    Government & third party

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    Private payers

9.1.2.1.        Market Revenue and Forecast (2016-2028)

9.1.3.    Hospital & medical practice

9.1.3.1.        Market Revenue and Forecast (2016-2028)

9.1.4.    Pharma biotech & medical device companies

9.1.4.1.        Market Revenue and Forecast (2016-2028)

9.1.5.    Research institutes

9.1.5.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Sequencing Reagents Market, By Application

10.1.        Sequencing Reagents Market, By Application, 2020-2028

10.1.1.  Oncology

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Reproductive Health

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  Clinical Investigation

10.1.3.1.      Market Revenue and Forecast (2016-2028)

10.1.4.  Agrigenomics & Forensics

10.1.4.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Sequencing Reagents Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.1.2.  Market Revenue and Forecast, By Reagent Type (2016-2028)

11.1.3.  Market Revenue and Forecast, by End User (2016-2028)

11.1.4.  Market Revenue and Forecast, By Application (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.5.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.1.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.5.4.      Market Revenue and Forecast, By Application (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.6.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.1.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.1.6.4.      Market Revenue and Forecast, By Application (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.2.2.  Market Revenue and Forecast, By Reagent Type (2016-2028)

11.2.3.  Market Revenue and Forecast, by End User (2016-2028)

11.2.4.  Market Revenue and Forecast, By Application (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.5.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.2.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.5.4.      Market Revenue and Forecast, By Application (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.6.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.2.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.6.4.      Market Revenue and Forecast, By Application (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.7.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.2.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.7.4.      Market Revenue and Forecast, By Application (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.8.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.2.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.2.8.4.      Market Revenue and Forecast, By Application (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.3.2.  Market Revenue and Forecast, By Reagent Type (2016-2028)

11.3.3.  Market Revenue and Forecast, by End User (2016-2028)

11.3.4.  Market Revenue and Forecast, By Application (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.5.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.3.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.5.4.      Market Revenue and Forecast, By Application (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.6.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.3.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.6.4.      Market Revenue and Forecast, By Application (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.7.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.3.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.7.4.      Market Revenue and Forecast, By Application (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.8.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.3.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.3.8.4.      Market Revenue and Forecast, By Application (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.4.2.  Market Revenue and Forecast, By Reagent Type (2016-2028)

11.4.3.  Market Revenue and Forecast, by End User (2016-2028)

11.4.4.  Market Revenue and Forecast, By Application (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.5.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.4.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.5.4.      Market Revenue and Forecast, By Application (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.6.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.4.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.6.4.      Market Revenue and Forecast, By Application (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.7.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.4.7.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.7.4.      Market Revenue and Forecast, By Application (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.8.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.4.8.3.      Market Revenue and Forecast, by End User (2016-2028)

11.4.8.4.      Market Revenue and Forecast, By Application (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.5.2.  Market Revenue and Forecast, By Reagent Type (2016-2028)

11.5.3.  Market Revenue and Forecast, by End User (2016-2028)

11.5.4.  Market Revenue and Forecast, By Application (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.5.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.5.5.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.5.4.      Market Revenue and Forecast, By Application (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.6.2.      Market Revenue and Forecast, By Reagent Type (2016-2028)

11.5.6.3.      Market Revenue and Forecast, by End User (2016-2028)

11.5.6.4.      Market Revenue and Forecast, By Application (2016-2028)

Chapter 12.  Company Profiles

12.1.              Thermo Fisher Scientific, Inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Illumina, Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              QIAGEN

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              BGI

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Pacific Biosciences of California, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              F. Hoffmann-La Roche AG

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Oxford Nanopore Technologies

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Agilent Technologies, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Fluidigm Corporation

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           ArcherDX, Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Takara Bio Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Bioline.

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms